Key Takeaways GLP-1 receptor agonists, including Tirzepatide, Semaglutide, and Liraglutide, are effective in promoting weight loss and improving glycemic control, with varying degrees of effectiveness and administration schedules
Thats why we take an individualized approach when creating a weight loss plan
With these positive data in hand, we are moving with urgency toward global regulatory submissions to potentially meet the needs of patients who are waiting, said Kenneth Custer, executive vice president of Eli Lilly and president of Lilly Cardiometabolic Health, in a statement from the company
Neurogastroenterol Motil 2010;22:664-e203.ArticlePubMed 26
The only exception, says Seltzer, is if youre taking it for a medical reason, like for a heart condition, and your cardiologist wants you to start at a higher dose for that purpose
A growing number of products are being marketed specifically for GLP-1 medication users